A Study to Evaluate the Effect of Precision Spectra™ Programming Features and Lead Options on Patient Outcomes

Stopped early · Not applicable

Conditions studied: Chronic Pain

In brief

The study is a prospective, on-label, multi-center, blinded, randomized controlled trial with a cross-over design to evaluate the effect of Precision Spectra™ SCS System's programming features and lead options.

Key facts

Study ID

NCT02384096

Run by

Boston Scientific Corporation

People needed

17

Starts

2015-02-01

Expected to finish

2016-10-01

Last updated by the study team

2020-11-20

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Meets RELIEF Registry criteria for inclusion
• Primary complaint of persistent or recurrent low back pain, with or without leg pain
• Signed a valid, IRB/EC-approved informed consent form

You may not qualify if…

• Meets any RELIEF Registry criteria for exclusion

Where it is running

• Physicians Research Group, LLC — Phoenix, Arizona, United States
• Albany Medical Center — Albany, New York, United States
• PCPMG Clinical Research Unit, LLC — Greenville, South Carolina, United States
• Spine Team Texas — Rockwall, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.